Table 1.
Baseline characteristics of patients in RISCA, PRAXY, and TRIUMPH
| RISCA n=1040 |
PRAXY n=691 |
TRIUMPH n=1772 |
|
|---|---|---|---|
| Age (yrs), mean (sd) | 61.8 (11.4) | 48 (5.6) | 59.93 (11.9) |
| Female, n (%) | 254 (24.4) | 192 (27.8) | 485 (27.4) |
| Previous CVD, n (%) | 577 (55.5) | 275 (39.8) | 1102 (62.2) |
| Previous revascularization, n (%) | 296 (28.5) | 101 (14.6) | 468 (26.4) |
| Hypertension, n (%) | 525 (50.5) | 314 (45.4) | 1067 (60.2) |
| Diabetes, n (%) | 204 (19.6) | 108 (15.6) | 437 (24.7) |
| Hypercholesterolemia, n (%) | 644 (61.9) | 380 (55.0) | 899 (50.7) |
| BMI (kg/m2), mean (sd) | 27.2 (4.4) | 29.4 (6.3) | 29.58 (6.3) |
| Current smoker, n (%) | 313 (30.1) | 302 (43.7) | 642 (36.2) |
| Coronary angiogram, n (%) | 588 (56.5) | 572 (82.8) | 1711 (96.6) |
| Medications at discharge | |||
| ASA, n (%) | 952 (91.5) | 679 (98.3) | 1699 (95.9) |
| Other antiplatelet, n (%) | 431 (41.4) | 606 (87.7) | 1423 (80.3) |
| Beta-blocker, n (%) | 827 (79.5) | 598 (86.5) | 1627 (91.8) |
| Statin, n (%) | 806 (77.5) | 651 (94.2) | 1586 (89.5) |
| ACE-I or ARB, n (%) | 609 (58.6) | 688 (99.6) | 1302 (73.5) |
| GRACE risk score, mean (sd) | 118.1 (39.2) | 87.6 (18.6) | 99.5 (28.8) |
GRS: genetic risk score, sd: standard deviation, CVD cardiovascular disease, BMI body mass index, ASA acetylsalicylic acid, ACE-I angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker,